Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Depression 4 Anxiety Disorders 4 Palliative Care 2 Fatigue 2 Caregiver Burden 2 Caregiver 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Pain 1 Multiple Myeloma 1 Lung Neoplasms 1 Health Status Unknown 1 Glioma 1 Dyspnea 1 Caregivers With a Child Followed up With a Cancer Diagnosis 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Diagnosis 1 Breast Carcinoma In Situ 1

Interventions

Dexamethasone 809 Bortezomib 449 Lenalidomide 430 Cyclophosphamide 336 Melphalan 251 Calcium Dobesilate 237 daratumumab 218 pomalidomide 202 carfilzomib 181 fludarabine phosphate 131 Thalidomide 121 fludarabine 118 Peripheral Blood Stem Cell Transplantation 117 Filgrastim 111 ixazomib 85 Mycophenolic Acid 85 Granulocyte Colony-Stimulating Factor 84 Busulfan 83 Whole-Body Irradiation 80 Tacrolimus 75 dexamethasone acetate 74 Cyclosporine 67 isatuximab 64 Prednisone 64 dexamethasone 21-phosphate 63 elotuzumab 60 auricularum 57 belantamab mafodotin 55 Antilymphocyte Serum 55 Etoposide 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Caregivers × Clear all

NCT07276230 2025-12-29

ENTRAIDANT

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡